{"database": "openregs", "table": "dockets", "rows": [["FDA-2025-P-6024", "FDA", "Requests that FDA declare that Clemastine Fumarate Oral Syrup, 0.25 mg base/5 mL, 0.75 mg base/5 mL, and 1 mg base/5 mL, is suitable for submission in an ANDA", "Nonrulemaking", "2026-05-15T21:50:33Z", "0b000064b907e179"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2025-P-6024"], "units": {}, "query_ms": 0.3527409862726927, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}